Recent study has demonstrated a link between IDH1 function and BCAT1 expression in gliomas, as BCAT1 was shown to be involved in tumor growth and disease progression only in gliomas with wild-type (non-mutated) IDH1 [16]. This evidence concerns the gene BCAT1 and central nervous system cancer.